Nektar Therapeutics | NKTR - Despesas Operacionais





Despesas Operacionais Alterar Data
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
ALKERMES USD 1.86B 56.17M 2026-09
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Amgen USD 5.69B 6B 2026-09
Baxter International USD 6.5B 3.82B 2026-09
BioCryst Pharmaceuticals USD -397.38M 517.17M 2026-09
Biogen USD 2.32B 663.6M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Cara Therapeutics USD 7.05M 1.11M 2026-03
Cipla INR 63.61B 1.3B 2026-09
Dr.Reddys Laboratories INR 74.82B 2.93B 2026-09
Eisai JPY 209.6B 6.14B 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 390.27M 10M 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Grifols EUR 1.99B 217.4M 2025-12
Halozyme Therapeutics USD 198M 4.66M 2026-09
Incyte USD 5.64B 4.67B 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Merck USD 10.75B 5.02B 2026-09
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Neurocrine Biosciences USD 779.7M 40.6M 2026-09
Novartis USD 9.88B 325M 2026-09
Pfizer USD 89B 3.81B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Takeda JPY 981.78B 36.71B 2026-09
Teva Pharmaceutical Industries USD 3.18B 733M 2026-09
Xencor USD 87.82M 5.44M 2026-06